Relay Therapeutics, Inc. (RLAY) earnings
RLAY earnings moved a median of -2.80% by the close. Quarterly and annual RLAY reports and results, each read against the price at its own news timestamp. Back to the RLAY overview →
30 measured RLAY earnings events.
Where these RLAY earnings landedvs 30 measured RLAY earnings reactions
| Middle 50% of RLAY earnings reactions | -4.71% to +1.22% |
|---|---|
| Median reaction (to close) | -2.80% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 RLAY earnings events with a measured close landed between -4.71% and +1.22%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Relay Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.78% | +2.86% | |
| Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates | Press release | -0.78% | +2.86% | |
| Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026 | Press release | -1.77% | -4.71% | |
| Form 10-Q Relay Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.46% | +1.49% | |
| Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates | Press release | -3.46% | +1.49% | |
| Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026 | Press release | -0.23% | +1.09% | |
| Form 10-K Relay Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.68% | +6.43% | |
| Form 10-Q Relay Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.12% | -1.14% | |
| Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates | Press release | +2.12% | -1.14% | |
| Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 | Press release | -0.14% | -2.59% | |
| Form 10-Q Relay Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.57% | +1.26% | |
| Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates | Press release | +1.57% | +1.26% | |
| Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 | Press release | +0.00% | -3.17% | |
| Form 10-Q Relay Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.13% | -4.25% | |
| Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | Press release | -2.13% | -4.25% | |
| Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025 | Press release | -1.24% | -4.03% | |
| Form 10-K Relay Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +12.92% | +0.00% | |
| Form 10-Q Relay Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.95% | -3.00% | |
| Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights | Press release | +0.95% | -3.00% | |
| Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 | Press release | -0.09% | -0.09% | |
| Form 10-Q Relay Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.07% | -5.02% | |
| Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights | Press release | +0.07% | -5.02% | |
| Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024 | Press release | -3.37% | -0.96% | |
| Form 10-Q Relay Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -9.41% | -19.17% | |
| Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights | Press release | -9.41% | -19.17% | |
| Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 | Press release | -1.38% | +3.58% | |
| Form 10-K Relay Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -6.46% | -7.66% | |
| Form 10-Q Relay Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.12% | -10.05% | |
| Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights | Press release | +0.12% | -10.05% | |
| Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023 | Press release | +0.47% | -4.72% |
Keep exploring
More RLAY: analyst actions → · SEC filings → · RLAY overview →